Author:
Reinders Margot T.M.,van Meer Suzanne,Burgmans Mark C.,de Jong Koert P.,Klümpen Heinz-Josef,de Man Robert A.,Ramsoekh D. (Sandjai),Sprengers Dave,Tjwa Eric T.T.L.,de Vos-Geelen Judith,van Erpecum Karel J.,van der Geest Lydia G.M.
Funder
KWF Kankerbestrijding
Boston Scientific
BTG, United Kingdom
Terumo
LSH
Maag Lever Darm Stichting
Covidien
Servier
Reference21 articles.
1. Corrigendum to "EASL clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2019
2. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology (Baltimore, Md),2018
3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
4. International trends in hepatocellular carcinoma incidence, 1978–2012;Petrick;Int J Canc,2020
5. Diagnostics and treatment of hepatocellular carcinoma: trends in The Netherlands in the period 2003-2011;van Meer;Ned Tijdschr Geneeskd,2014
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献